gene therapy - search results

A new campaign from the Terrence Higgins Trust aims to debunk some of the myths and beliefs surrounding HIV

University of Oulu’s Professor Riitta Veijola discusses the impact of Type 1 diabetes on society and the challenges associated with tackling the disease

University of Strathclyde’s Professor Colin J Suckling shares research being undertaken into anti-infective and immunomodulatory drug discovery programmes

David H Peyton at Portland State University outlines how research has discovered that heme is key to malaria drug development

University of Illinois’ Dr. Benjamin Van Voorhees explains how the CATCH-IT intervention is fighting against depression using a behavioural vaccine approach

Photodynamic Therapy (PDT) is a method of killing cells which utilizes a photosensitizing drug (usually a porphyrin of some type), light within the visible light spectrum of a wave length consistent with absorption characteristics of the specific sensitizer being used, and oxygen in tissues. These 3 factors have to...

It is estimated that ten percent of the costs of health care in Switzerland (or an equivalent of 500 billion Euros per annum in the EU) being associated with lost work is related to injury or dysfunction of the musculoskeletal system Surgical and subsequent rehabilitative interventions are an important part...

Associate Professor of Medical Genetics, Silvia Deaglio, highlights the research strides being made in the fight against chronic lymphocytic leukemia

Manuela Côrte-Real outlines how yeast can clarify the regulation of cell death pathways and provide new therapeutic strategies for human diseases

The European Federation of Pharmaceutical Industries and Associations (EFPIA) explain how SAFE-T DIKI is advancing research into drug-induced kidney injury

Uterine fibroids represent a prevalent benign gynaecologic problem in the U.S, here Romana A. Nowak of the University of Illinois explains

The human genome is composed of over 3 billion letters, here Dr Yuval Ebenstein, Principal Investigator, Tel Aviv University sheds light on it.

Canadian Cancer Society’s Dr Rob Nuttall and Shawn Chirrey explain how fighting against breast cancer requires ongoing support for research and screening

Prof Colin J Suckling, University of Strathclyde's Department of Pure & Applied Chemistry, discusses heterocyclic chemistry.

Dr. Lisa Halvorson, U.S. National Institutes of Health discusses the importance of gynaecologic research to develop new treatments and keep women healthy

Can we prevent the muscle loss associated with some cancers? Dr Vera Mazurak at the University of Alberta is looking into one method of treating myosteatosis Pathological fat infiltration into muscle is a feature of disease-induced muscle loss that significantly associates with shorter survival in people with cancer. Fat is...

Professor Martin Flück and colleagues at Balgrist University Hospital's Laboratory for Muscle Plasticity investigate possible therapies for weak muscles It is estimated that 10% of the costs of healthcare in Switzerland (or an equivalent of 500 billion Euros per annum in the EU) associated with lost work are related to injury or...

By providing the infrastructure to support drug discovery, the IMI is accelerating access to innovative medicines, as the EFPIA highlights here Innovation is the lifeblood of the pharmaceutical industry, providing us with the potential to cross new therapeutic frontiers to bring novel medicines to market that benefit patients and deliver...

Dr Mehis Pilv, CEO and business development lead at Genecode, discusses the strides being made in Parkinson's disease research Parkinson's disease is a slow but progressive neurodegenerative disorder. About 1% of people aged above 50 are affected worldwide. In Europe alone 1.2 million people suffer from Parkinson's disease, 127,000 of whom...

Better understanding of the factors at play will enable efforts to reduce HIV transmission in Southern and Eastern Africa, where incidence rates are highest The global HIV epidemic peaked at 3 million new infections in the year 2000. However, since 2010 the decline has stalled at 2 million new infections...